The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
NCT01289652 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2014-04-23
Summary
The aim of the study is to investigate the epidemiology, natural history and treatment outcomes of acute hepatitis C (HCV) infection. Given the current pattern of case reporting, the cohort will be largely made up of human immunodeficiency virus (HIV)-positive patients, but HIV-negative patients with acute hepatitis C (AHC) will also be enrolled to enable comparisons to be made as appropriate and possible.
Conditions
- Acute Hepatitis C
- HIV
Sponsors & Collaborators
-
Benedetta Mattioli
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2016-05-31
- Completion
- 2017-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy
NCT05929963 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection
NCT02604017 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)
NCT00724451 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection
NCT02707952 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks
NCT03122132 ·Status: COMPLETED
-
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P
NCT02634008 ·Status: COMPLETED ·Phase: PHASE3
-
Qualification of Point-of-Care Assays for Management of HCV Patients
NCT02335320 ·Status: UNKNOWN
-
A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
NCT02966795 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals
NCT02568332 ·Status: COMPLETED ·Phase: PHASE1
-
Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C
NCT02526641 ·Status: COMPLETED
-
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside
NCT03513796 ·Status: COMPLETED
-
Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)
NCT00709228 ·Status: COMPLETED
-
The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)
NCT02636595 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary
NCT02636608 ·Status: COMPLETED
-
An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)
NCT01344889 ·Status: COMPLETED
-
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
NCT00736242 ·Status: COMPLETED
-
Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL)
NCT02582658 ·Status: COMPLETED
-
Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients
NCT02969668 ·Status: COMPLETED
-
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
NCT01718301 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals
NCT05062408 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
NCT02738138 ·Status: COMPLETED ·Phase: PHASE3
-
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C
NCT01859962 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
NCT01463956 ·Status: COMPLETED ·Phase: PHASE2
-
Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia
NCT02511496 ·Status: UNKNOWN
-
Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting
NCT00222859 ·Status: COMPLETED